相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Commonly Used Pancreatic Stellate Cell Cultures Differ Phenotypically and in Their Interactions with Pancreatic Cancer Cells
Daniela Lenggenhager et al.
CELLS (2019)
Therapeutic developments in pancreatic cancer: current and future perspectives
John P. Neoptolemos et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Cancer-associated fibroblasts promote directional cancer cell migration by aligning fibronectin
Begum Erdogan et al.
JOURNAL OF CELL BIOLOGY (2017)
Biology of pancreatic stellate cells-more than just pancreatic cancer
Pawel E. Ferdek et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2017)
Functional heterogeneity in tumor-derived human pancreatic stellate cells: Differential expression of HGF and implications for mitogenic signaling and migration in pancreatic cancer cells
Vegard Tjomsland et al.
ONCOTARGET (2017)
Pancreatic Cancer Chemoresistance to Gemcitabine
Manoj Amrutkar et al.
CANCERS (2017)
Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are going
Chen Liang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts
Dietrich A. Ruess et al.
DRUGS & AGING (2017)
Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study
Knut J. Labori et al.
ACTA ONCOLOGICA (2016)
Does long-term survival exist in pancreatic adenocarcinoma?
Myrte Zijlstra et al.
ACTA ONCOLOGICA (2016)
Matrix control of pancreatic cancer: New insights into fibronectin signaling
Mary Topalovski et al.
CANCER LETTERS (2016)
Key role of pancreatic stellate cells in pancreatic cancer
Srinivasa P. Pothula et al.
CANCER LETTERS (2016)
TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3
Rachel A. Hesler et al.
CARCINOGENESIS (2016)
Genetics and biology of pancreatic ductal adenocarcinoma
Haoqiang Ying et al.
GENES & DEVELOPMENT (2016)
Chemotherapy-Induced Inflammatory Gene Signature and Protumorigenic Phenotype in Pancreatic CAFs via Stress-Associated MAPK
Paul A. Toste et al.
MOLECULAR CANCER RESEARCH (2016)
Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer
Yang Liu et al.
TUMOR BIOLOGY (2016)
Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma
Xianda Zhao et al.
ONCOTARGET (2016)
Increased Expression of Several Collagen Genes is Associated with Drug Resistance in Ovarian Cancer Cell Lines
Radoslaw Januchowski et al.
JOURNAL OF CANCER (2016)
Pancreatic cancer
Jorg Kleeff et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Orchestrating the Tumor Microenvironment to Improve Survival for Patients With Pancreatic Cancer Normalization, Not Destruction
Clifford J. Whatcott et al.
CANCER JOURNAL (2015)
pERK1/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expression
Min Wang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2015)
Role of fibronectin in normal wound healing
Ellie A. Lenselink
INTERNATIONAL WOUND JOURNAL (2015)
Inhibitory effects of prostaglandin E2 on collagen synthesis and cell proliferation in human stellate cells from pancreatic head adenocarcinoma
Ewa Pomianowska et al.
BMC CANCER (2014)
The stromal compartments in pancreatic cancer: Are there any therapeutic targets?
Serena Lunardi et al.
CANCER LETTERS (2014)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer
Lucas de Sousa Cavalcante et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Stars and stripes in pancreatic cancer: role of stellate cells and stroma in cancer progression
Jeremy S. Wilson et al.
FRONTIERS IN PHYSIOLOGY (2014)
ERK1/2 activity contributes to gemcitabine resistance in pancreatic cancer cells
Chunning Zheng et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2013)
Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes
Raghu Kadaba et al.
JOURNAL OF PATHOLOGY (2013)
Three-Dimensional Collagen I Promotes Gemcitabine Resistance In Vitro in Pancreatic Cancer Cells through HMGA2-Dependent Histone Acetyltransferase Expression
Surabhi Dangi-Garimella et al.
PLOS ONE (2013)
Biochemical role of the collagen-rich tumour microenvironment in pancreatic cancer progression
Mario A. Shields et al.
BIOCHEMICAL JOURNAL (2012)
Dangerous liaisons: Pancreatic stellate cells and pancreatic cancer cells
Minoti V. Apte et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Three-Dimensional Collagen I Promotes Gemcitabine Resistance in Pancreatic Cancer through MT1-MMP-Mediated Expression of HMGA2
Surabhi Dangi-Garimella et al.
CANCER RESEARCH (2011)
Stromal biology and therapy in pancreatic cancer
Albrecht Neesse et al.
GUT (2011)
Plasma and cellular fibronectin: distinct and independent functions during tissue repair
Wing S. To et al.
FIBROGENESIS & TISSUE REPAIR (2011)
Gene expression analysis of drug-resistant MCF-7 cells: implications for relation to extracellular matrix proteins
Oezlem Darcansoy Iseri et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
Thiruvengadam Arumugam et al.
CANCER RESEARCH (2009)
Roles of Pancreatic Stellate Cells in Pancreatic Inflammation and Fibrosis
Atsushi Masamune et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Clinical pharmacology and pharmacogenetics of gemcitabine
Andrea Wong et al.
DRUG METABOLISM REVIEWS (2009)
Genetic and cell biological analysis of integrin outside-in signaling
Kyle R. Legate et al.
GENES & DEVELOPMENT (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Pancreatic stellate cells: Partners in crime with pancreatic cancer cells
Alain Vonlaufen et al.
CANCER RESEARCH (2008)
Nuclear Factor-κB p65/relA Silencing Induces Apoptosis and Increases Gemcitabine Effectiveness in a Subset of Pancreatic Cancer Cells
Xue Pan et al.
CLINICAL CANCER RESEARCH (2008)
Gemcitabine resistance in pancreatic cancer: Picking the key players
Michael P. Kim et al.
CLINICAL CANCER RESEARCH (2008)
Basement membrane proteins play an important role in the invasive processes of human pancreatic cancer cells
Hirozumi Sawai et al.
JOURNAL OF SURGICAL RESEARCH (2008)
The integrin-extracellular matrix axis in pancreatic cancer
John J. Grzesiak et al.
PANCREAS (2007)
Activated Akt and Erk expression and survival after surgery in pancreatic carcinoma
Krishdeep S. Chadha et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma
S Yamamoto et al.
CLINICAL CANCER RESEARCH (2004)
Inhibition of Src tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells
MS Duxbury et al.
CLINICAL CANCER RESEARCH (2004)
Determinants of sensitivity and resistance to gemcitabine: The roles of human equilibrative nucleoside transporter 1 and deoxycytidine kinase in non-small cell lung cancer
H Achiwa et al.
CANCER SCIENCE (2004)
Tumor-stroma interaction of human pancreatic cancer: Acquired resistance to anticancer drugs and proliferation regulation is dependent on extracellular matrix proteins
H Miyamoto et al.
PANCREAS (2004)
Role of NF-κB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death
A Arlt et al.
ONCOGENE (2003)
Fibronectin in malignancy - Effect of aging
J Labat-Robert
SEMINARS IN CANCER BIOLOGY (2002)
KEGG: Kyoto Encyclopedia of Genes and Genomes
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2000)
分享论文
